n.moreau

TL2 · Konya

Contributes reviews on supplier material. Based in Konya.

Joined 5 February 2025 · last posted 1d

73Posts here

0Topics

2Solutions

153Likes received

189Likes given

17Badges

69Days visited

923Posts read

Recent activity

Full stream

Tracking a shortage from primary sources rather than rumour — the long version Replied, post #3 · marked as the solution · Access › Shortages · 27 Jul 2026 · 15 likes Regional differences during a shortage are large, and a supply position in one country says nothing about another. Happy to be the one who is wrong here if it settles…
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #25 · Analytics › COA interpretation · 25 Jul 2026 · 12 likes The fields that make one usable: lot identifier matching the container, test date, method identification specific enough to reproduce, the result as a number, and the…
BPC-157: what the rodent literature actually shows, and what it does not — does this… Replied, post #8 · Compounds › Repair & healing peptides · 20 Jul 2026 · 0 likes TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are routinely conflated in supplier documentation…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #96 · Compounds › Semaglutide · 8 Jul 2026 · 0 likes Post #93 answers the question as asked. The question underneath it is different. Albumin binding is not a unique structural feature and nothing in the class lacks it,…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #26 · Compounds › Retatrutide · 29 Jun 2026 · 0 likes Same experience here, different supplier, so it is at least not unique to one of them.
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #60 · Evidence › Journal club · 24 Jun 2026 · 3 likes Post #59 is the version of this I will quote in future. One addition. Source for the SURMOUNT-1 figure, since it was asked for. It is in the discussion rather than the…
Submitting a sample: the process end to end Replied, post #25 · Sourcing › Independent verification · 19 Jun 2026 · 24 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
Bioimpedance and hydration: why the number moves Replied, post #58 · Outcomes › Body composition · 10 Jun 2026 · 4 likes Post #54 put the caveat in the right place and I want to underline it. The most useful protocol is the one you will actually repeat identically. An imperfect…
Racemisation and why it is invisible to a mass measurement Replied, post #15 · Analytics › Impurities & related substances · 9 Jun 2026 · 29 likes Post #13 and I disagree about the size of the effect, not about the direction. Aggregates may be a multiple of the monomer mass and may not elute at all under a…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #32 · Compounds › Repair & healing peptides · 27 May 2026 · 15 likes Post #31 is the version of this I will quote in future. One addition. Stability of BPC-157 in solution: what has been measured in published work covers specific…
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #19 · Evidence › Trials · 10 May 2026 · 3 likes Coming back to post #17, because the follow-up matters more than the original answer. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #44 · Meta › Announcements · 10 May 2026 · 7 likes The moderation log will carry the announcement entry, so the date is recoverable. It will not be visible on the topic itself, which is probably the right level of…